{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:21:32Z","timestamp":1768710092697,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00535-025-02302-3","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:03:10Z","timestamp":1761822190000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost\u2013utility analysis of treatment strategies for chronic constipation in Japan"],"prefix":"10.1007","volume":"61","author":[{"given":"Mariko","family":"Hojo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5979-4384","authenticated-orcid":false,"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"5","key":"2302_CR1","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","volume":"158","author":"OS Palsson","year":"2020","unstructured":"Palsson OS, Whitehead W, T\u00f6rnblom H, Sperber AD, Simren M. Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020;158(5):1262-73.e3.","journal-title":"Gastroenterology"},{"key":"2302_CR2","doi-asserted-by":"crossref","unstructured":"Schmidt FM, Santos VL. Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs. 2014;41(1):70\u20136 (quiz E1\u20132).","DOI":"10.1097\/01.WON.0000438019.21229.b7"},{"key":"2302_CR3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology"},{"issue":"18","key":"2302_CR4","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.7150\/ijms.49648","volume":"17","author":"J Ruszkowski","year":"2020","unstructured":"Ruszkowski J, Heleniak Z, Kr\u00f3l E, Tarasewicz A, Ga\u0142gowska J, Witkowski JM, et al. Constipation and the quality of life in conservatively treated chronic kidney disease patients: a cross-sectional study. Int J Med Sci. 2020;17(18):2954\u201363.","journal-title":"Int J Med Sci"},{"issue":"Suppl 1","key":"2302_CR5","first-page":"S5","volume":"100","author":"LJ Brandt","year":"2005","unstructured":"Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(Suppl 1):S5-s21.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2302_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jama.2015.16994","volume":"315","author":"A Wald","year":"2016","unstructured":"Wald A. Constipation: advances in diagnosis and treatment. JAMA. 2016;315(2):185\u201391.","journal-title":"JAMA"},{"issue":"7","key":"2302_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1053\/j.gastro.2023.03.214","volume":"164","author":"L Chang","year":"2023","unstructured":"Chang L, Chey WD, Imdad A, Almario CV, Bharucha AE, Diem S, et al. American gastroenterological association-american college of gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation. Gastroenterology. 2023;164(7):1086\u2013106.","journal-title":"Gastroenterology"},{"key":"2302_CR8","unstructured":"Kasugai K, Yamamoto S, Kawamura Y, Adachi K, Yamaguchi Y, Tamura Y, et al. [Internet survey of the actual situation of constipation in Japanese general population REACTION-J:Research for Actual Situation of Constipation in the Japanese]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 2019;116(11):913\u201326."},{"issue":"1","key":"2302_CR9","first-page":"62","volume":"106","author":"E Ihara","year":"2025","unstructured":"Ihara E, Manabe N, Ohkubo H, Ogasawara N, Ogino H, Kakimoto K, et al. Evidence-based clinical guidelines for chronic constipation 2023. Digestion. 2025;106(1):62\u201389.","journal-title":"Digestion"},{"key":"2302_CR10","doi-asserted-by":"crossref","unstructured":"Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol. 2015;13(2):294\u2013301 (e5).","DOI":"10.1016\/j.cgh.2014.08.026"},{"issue":"1","key":"2302_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13487","volume":"31","author":"S Fukudo","year":"2019","unstructured":"Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako M, Hayashi K, et al. High-dose linaclotide is effective and safe in patients with chronic constipation: a phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. Neurogastroenterol Motil. 2019;31(1):e13487.","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"2302_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(18)30123-7","volume":"3","author":"A Nakajima","year":"2018","unstructured":"Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, et al. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(8):537\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"2302_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s00535-019-01581-x","volume":"54","author":"A Nakajima","year":"2019","unstructured":"Nakajima A, Shinbo K, Oota A, Kinoshita Y. Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension. J Gastroenterol. 2019;54(9):792\u2013803.","journal-title":"J Gastroenterol"},{"issue":"6","key":"2302_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00535-018-01545-7","volume":"54","author":"K Kasugai","year":"2019","unstructured":"Kasugai K, Iwai H, Kuboyama N, Yoshikawa A, Fukudo S. Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study. J Gastroenterol. 2019;54(6):530\u201340.","journal-title":"J Gastroenterol"},{"issue":"4","key":"2302_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5056\/jnm18194","volume":"25","author":"S Mori","year":"2019","unstructured":"Mori S, Tomita T, Fujimura K, Asano H, Ogawa T, Yamasaki T, et al. A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation. J Neurogastroenterol Motil. 2019;25(4):563\u201375.","journal-title":"J Neurogastroenterol Motil"},{"key":"2302_CR16","unstructured":"Mochida Pharmaceutical Co., Ltd., EA Pharma Co., Ltd. Interview form: Movicol\u00ae combination powder. Tokyo: Mochida Pharmaceutical Co., Ltd.; 2023 Nov. https:\/\/med.mochida.co.jp\/interview\/mvc_n9k.pdf. (in Japanese)"},{"key":"2302_CR17","volume-title":"Methods for the economic evaluation of health care programs","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. 4th ed. Oxford: Oxford University Press; 2015.","edition":"4"},{"issue":"3","key":"2302_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s41669-017-0065-9","volume":"2","author":"B Pennington","year":"2018","unstructured":"Pennington B, Marriott ER, Lichtlen P, Akbar A, Hatswell AJ. The cost effectiveness of Lubiprostone in chronic idiopathic constipation. Pharmacoecon Open. 2018;2(3):241\u201353.","journal-title":"Pharmacoecon Open"},{"key":"2302_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00067","volume":"6","author":"MJ Nuijten","year":"2015","unstructured":"Nuijten MJ, Dubois DJ, Joseph A, Annemans L. Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands. Front Pharmacol. 2015;6:67.","journal-title":"Front Pharmacol"},{"issue":"9","key":"2302_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10198-015-0747-0","volume":"17","author":"M Fisher","year":"2016","unstructured":"Fisher M, Walker A, Falqu\u00e9s M, Moya M, Rance M, Taylor D, et al. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland. Eur J Health Econ. 2016;17(9):1091\u2013100.","journal-title":"Eur J Health Econ"},{"issue":"4","key":"2302_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40273-018-0609-6","volume":"36","author":"D Han","year":"2018","unstructured":"Han D, Iragorri N, Clement F, Lorenzetti D, Spackman E. Cost effectiveness of treatments for chronic constipation: a systematic review. Pharmacoeconomics. 2018;36(4):435\u201349.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2302_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12876-023-03104-8","volume":"24","author":"SS Rao","year":"2024","unstructured":"Rao SS, Manabe N, Karasawa Y, Hasebe Y, Nozawa K, Nakajima A, et al. Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat\/harm. BMC Gastroenterol. 2024;24(1):12.","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02302-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:04:23Z","timestamp":1768471463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02302-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the missing institution name in affiliation 3 and missing equal contribution text.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mariko Hojo reports honorarium from Viatris Pharmaceuticals Japan Inc. and is affiliated with an endowed course supported by Yakult Honsha Co., Ltd. Ataru Igarashi reports honoraria from EA Pharma Co., Ltd, and Astellas Pharma Inc. Ayako Shoji reports consulting fees from Healthcare Consulting Inc. Akihito Nagahara reports honoraria from Astellas Pharma Inc., EA Pharma Co., Ltd, Tsumura & Co., and Viatris Pharmaceuticals Japan Inc., and is affiliated with an endowed course supported by Yakult Honsha Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}